DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Cipla Share Price Live Updates: Cipla Stock Details

Economic Times 5 hrs ago·21 Aug 2026, 3:20 am

Cipla's share price is currently in focus, reflecting the broader market's reaction to the company's latest performance and strategic developments. Investors are closely monitoring the stock as it moves in line with sector trends and company-specific news.

This movement matters to investors because it signals the market's current sentiment towards the pharmaceutical giant. Changes in share price often reflect investor expectations regarding the company's growth prospects, product pipeline, and overall financial health.

What to watch next includes the company's upcoming quarterly earnings reports, new product launches, and any updates on regulatory approvals. These factors will be key in determining the stock's future trajectory.